Kathleen Van Asten

Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial

Patrick Neven, Lynn Jongen, Anneleen Lintermans et al. · Clinical Cancer Research · 2018 · 59 citations · Full text

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients

Matteo Lambertini, Ana Catarina Pinto, Lieveke Ameye et al. · British Journal of Cancer · 2016 · 53 citations · Full text

A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI

Anneleen Lintermans, Kathleen Van Asten, Hans Wildiers et al. · Breast Cancer Research and Treatment · 2014 · 44 citations

Breast Oncology, Breast Cancer Patients, Medicine +8

Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer

Kathleen Van Asten, Laurence Slembrouck, Siel Olbrecht et al. · The Oncologist · 2018 · 41 citations · Full text

Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients

Anneleen Lintermans, Kathleen Van Asten, Lynn Jongen et al. · European Journal of Cancer · 2016 · 32 citations

Genetic Variant, Breast Oncology, Breast Cancer Patients +8